Abiopharma

🔍 Drucker Mann Lindsay (Executive)

Company: Oddity Tech Ltd (ODD)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 23,929 shares of Class A ordinary shares (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 58,658.00 | transaction_form_type: 4
• Sold 9,604 shares of Class A ordinary shares at $12.85 per share (Direct)
  Date: 2026-03-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 49,054.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 23,929 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 837,522.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2

Footnotes:

• F1: Represents the number of Class A ordinary shares sold in connection with the vesting of Restricted Stock Units ("RSUs") solely to satisfy statutory tax withholding obligations incurred upon vesting.
• F2: RSUs convert into Class A ordinary shares on a one-for-one basis. The first installment of the award is vested, and the remainder will vest in approximately equal installments on the last day of every calendar month, with the last installment to vest on February 28, 2029.